Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Other Accumulated Expenses: 2022

Historic Other Accumulated Expenses for Dianthus Therapeutics (DNTH) over the last 1 years, with Dec 2022 value amounting to $364,000.

  • Dianthus Therapeutics' Other Accumulated Expenses was N/A to $279,000 in Q2 2023 from the same period last year, while for Jun 2023 it was $279,000, marking a year-over-year change of. This contributed to the annual value of $364,000 for FY2022, which is N/A change from last year.
  • According to the latest figures from FY2022, Dianthus Therapeutics' Other Accumulated Expenses is $364,000.
  • In the past 5 years, Dianthus Therapeutics' Other Accumulated Expenses ranged from a high of $364,000 in FY2022 and a low of $364,000 during FY2022.
  • For the 1-year period, Dianthus Therapeutics' Other Accumulated Expenses averaged around $364,000, with its median value being $364,000 (2022).